Literature DB >> 26603106

Prediction of carotid artery in-stent restenosis by quantitative assessment of vulnerable plaque using computed tomography.

Kouichi Misaki1, Naoyuki Uchiyama2, Masanao Mohri2, Yutaka Hayashi2, Fumiaki Ueda3, Mitsutoshi Nakada2.   

Abstract

BACKGROUND AND
PURPOSE: To assess the relationship between plaque volume evaluated by multidetector computed tomographic angiography (MDCT) and in-stent restenosis (ISR) after carotid artery stenting (CAS).
MATERIALS AND METHODS: From a retrospectively maintained database, data were collected for 52patients with carotid artery stenosis treated with CAS between 2007 and 2012. We defined ISR of≥50% as a peak systolic velocity≥200cm/s on echo-duplex scan. Carotid plaques were subdivided into four components according to radiodensity in Hounsfield units (HU) as follows: <0, 0-60, 60-130, and>600HU. Risk factors that influenced ISR were compared using univariate and multivariate Cox regression analyses.
RESULTS: During a median follow-up period of 36months, ISR of≥50% was detected in five patients (9.6%). In the univariate Cox proportional hazard regression analysis, renal insufficiency, coronary artery disease, total plaque volume, and plaque volumes with radiodensities<0 and≥600HU increased the risk for ISR (P<0.10). When the significant risk factors determined from the univariate analysis were subjected to a multivariate analysis, only the volumes of the plaque components with radiodensities<0 HU independently predicted the development of ISR (hazard ratio: 1.041; 95% confidence interval: 1.006-1.078; P=0.021).
CONCLUSION: Our data suggest that the high volume of the plaque components with radiodensities<0HU was independently associated with the increased risk of ISR after CAS. Quantitative and qualitative tissue characterizations of carotid plaques using MDCT might be a useful predictive tool of the development of ISR.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Carotid artery stenting; Carotid plaque; In-stent restenosis; Multidetector computed tomography

Mesh:

Year:  2015        PMID: 26603106     DOI: 10.1016/j.neurad.2015.09.002

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  6 in total

1.  Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation.

Authors:  Zheng Qin; Fang-Wu Zheng; Chuang Zeng; Kuo Zhou; Yu Geng; Jian-Long Wang; Yue-Ping Li; Qing-Wei Ji; Yu-Jie Zhou
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

2.  New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.

Authors:  Jian-Long Wang; Zheng Qin; Zhi-Jian Wang; Dong-Mei Shi; Yu-Yang Liu; Ying-Xin Zhao; Li-Xia Yang; Wan-Jun Cheng; Yu-Jie Zhou
Journal:  J Geriatr Cardiol       Date:  2018-02       Impact factor: 3.327

3.  Risk Factors for Residual Stenosis After Carotid Artery Stenting.

Authors:  Yunlu Tao; Yang Hua; Lingyun Jia; Liqun Jiao; Beibei Liu
Journal:  Front Neurol       Date:  2021-01-28       Impact factor: 4.003

4.  Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.

Authors:  Bo-Wen Chen; Jia-Jing Liu; Jun-Hui Xing; Heng-Dao Liu; Yu-Zhen Wei; Xiao-Fei Xue; He-Ping Gu; Hai-Long Tao
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

5.  Calcification in original plaque and restenosis following carotid artery stenting.

Authors:  Hiroyuki Katano; Yusuke Nishikawa; Hiroshi Yamada; Mitsuhito Mase
Journal:  Surg Neurol Int       Date:  2017-11-20

Review 6.  The management of carotid restenosis: a comprehensive review.

Authors:  Francesco Stilo; Nunzio Montelione; Rosalinda Calandrelli; Marisa Distefano; Francesco Spinelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  Ann Transl Med       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.